The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …
V Haufroid, M Mourad, V Van Kerckhove… - Pharmacogenetics …, 2004 - journals.lww.com
Cyclosporine and tacrolimus are immunosuppressive drugs largely used in renal
transplantation. They are characterized by a wide inter-individual variability in their …
transplantation. They are characterized by a wide inter-individual variability in their …
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …
V Haufroid, M Mourad, V Van Kerckhove… - …, 2004 - dial.uclouvain.be
Cyclosporine and tacrolimus are immunosuppressive drugs largely used in renal
transplantation. They are characterized by a wide inter-individual variability in their …
transplantation. They are characterized by a wide inter-individual variability in their …
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …
V Haufroid, M Mourad, V Van Kerckhove… - …, 2004 - pubmed.ncbi.nlm.nih.gov
Cyclosporine and tacrolimus are immunosuppressive drugs largely used in renal
transplantation. They are characterized by a wide inter-individual variability in their …
transplantation. They are characterized by a wide inter-individual variability in their …
[引用][C] The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …
V HAUFROID - Pharmacogenetics, 2004 - cir.nii.ac.jp
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus
dose requirements and trough blood levels in stable renal transplant patients | CiNii Research …
dose requirements and trough blood levels in stable renal transplant patients | CiNii Research …
[引用][C] The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …
V HAUFROID, M MOURAD… - Pharmacogenetics …, 2004 - pascal-francis.inist.fr
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus
dose requirements and trough blood levels in stable renal transplant patients CNRS Inist …
dose requirements and trough blood levels in stable renal transplant patients CNRS Inist …
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …
V Haufroid, M Mourad, V Van Kerckhove… - …, 2004 - europepmc.org
Cyclosporine and tacrolimus are immunosuppressive drugs largely used in renal
transplantation. They are characterized by a wide inter-individual variability in their …
transplantation. They are characterized by a wide inter-individual variability in their …
[引用][C] The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …
V Haufroid, M Mourad - Pharmacogenetics, 2004 - cir.nii.ac.jp
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose
requirements and trough blood levels in stable renal transplant patients | CiNii Research CiNii …
requirements and trough blood levels in stable renal transplant patients | CiNii Research CiNii …